Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals had revenue of $45.33M in the quarter ending March 31, 2025, with 46.34% growth. This brings the company's revenue in the last twelve months to $181.49M, up 53.40% year-over-year. In the year 2024, Ligand Pharmaceuticals had annual revenue of $167.13M with 27.28% growth.

• Revenue (ttm): $181.49M
• Revenue Growth: +53.40%
• P/S Ratio: 15.14
• Revenue / Employee: $2,668,941
• Employees: 68
• Market Cap: 2.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	167.13M	35.82M	27.28%
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	47.68%
Dec 31, 2020	163.56M	43.28M	35.98%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.